Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-10 Sale |
2022-01-12 7:25 pm |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $12 | $12,000 | 94,385 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-14 8:48 pm |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $14.76 | $14,760 | 69,948 (Direct) |
View |
| 2021-03-30 Purchase |
2021-12-14 8:29 pm |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
125,000 | $16 | $2,000,000 | 4,143,544 (Indirect) |
View |
| 2021-12-10 Sale |
2021-12-14 8:29 pm |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
26,278 | $14.67 | $385,572 | 4,143,544 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-12-14 8:27 pm |
Ikena Oncology Inc. | IKNA | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
125,000 | $16 | $2,000,000 | 2,116,569 (Indirect Direct) |
View |
| 2021-12-10 Sale |
2021-12-14 8:27 pm |
Ikena Oncology Inc. | IKNA | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
26,278 | $14.67 | $385,572 | 2,116,569 (Indirect Direct) |
View |
| 2021-03-30 Purchase(A) |
2021-04-14 6:29 pm |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
423,400 | $16 | $6,774,400 | 10,525,539 (Indirect) |
View |
| 2021-03-30 Purchase(A) |
2021-04-13 6:36 pm |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
423,400 | $16 | $6,774,400 | 10,525,539 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:14 pm |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
423,400 | $16 | $6,774,400 | 10,499,175 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:13 pm |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
423,400 | $16 | $6,774,400 | 10,499,175 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-02-24 4:54 pm |
N/A 2029-07-10 |
Ikena Oncology Inc. | IKNA | Oliveira Francisco Principal Accounting Officer |
0 | $0 | 71,974 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 6:14 pm |
N/A 2032-02-02 |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 6:12 pm |
N/A 2032-02-02 |
Ikena Oncology Inc. | IKNA | Santillana Sergio L. Chief Medical Officer |
70,400 | $0 | 70,400 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:12 pm |
N/A 2032-02-03 |
Ikena Oncology Inc. | IKNA | Manfredi Mark President & CEO |
238,900 | $0 | 238,900 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 6:10 pm |
N/A 2032-02-02 |
Ikena Oncology Inc. | IKNA | Ecsedy Jeffrey Chief Development Officer |
59,360 | $0 | 59,360 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 6:09 pm |
N/A 2032-02-02 |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 9:34 pm |
N/A 2032-01-21 |
Ikena Oncology Inc. | IKNA | Wooster Richard Director |
29,200 | $0 | 29,200 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
38,915 | $2.94 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
8,265 | $4.51 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
24,606 | $4.15 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A 2028-08-08 |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
71,786 | $0 | 146,287 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-12 7:25 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $2.1462 | 94,385 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-12 7:25 pm |
N/A 2028-12-17 |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $0 | 94,385 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:46 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Koehler Maria Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:43 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Stampacchia Otello Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:43 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:39 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Dukes Iain D. Director |
23,419 | $0 | 23,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:35 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 6:28 pm |
N/A 2031-12-21 |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
13,419 | $0 | 13,419 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 8:48 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $2.1462 | 69,948 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 8:48 pm |
N/A 2028-12-17 |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
1,000 | $0 | 69,948 (Direct) |
View |
| 2021-11-22 Option Award |
2021-11-23 9:01 pm |
N/A 2031-11-21 |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
176,699 | $0 | 176,699 (Direct) |
View |
Ownership |
2021-11-23 8:58 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Zhang Xiaoyan Michelle Chief Scientific Officer |
0 | $0 | 182,079 (Direct) |
View |
| 2021-04-15 Option Award(A) |
2021-05-03 7:05 pm |
N/A 2031-04-15 |
Ikena Oncology Inc. | IKNA | Koehler Maria Director |
26,838 | $0 | 26,838 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-15 6:55 pm |
N/A 2031-04-15 |
Ikena Oncology Inc. | IKNA | Koehler Maria Director |
26,838 | $0 | 26,838 (Direct) |
View |
| 2020-12-21 Option Award(A) |
2021-04-14 6:29 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
10,368,251 | $1.3985 | 10,525,539 (Indirect) |
View |
| 2021-03-30 Conversion(A) |
2021-04-14 6:29 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
13,999,692 | $0 | 10,525,539 (Indirect) |
View |
| 2020-12-21 Option Award(A) |
2021-04-13 6:36 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
10,368,251 | $1.3985 | 10,525,539 (Indirect) |
View |
| 2021-03-30 Conversion(A) |
2021-04-13 6:36 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
13,999,692 | $0 | 10,525,539 (Indirect) |
View |
| 2020-12-21 Option Award |
2021-04-01 6:23 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
5,362,888 | $1.3985 | 6,112,522 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:23 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
38,734,459 | $0 | 6,112,522 (Indirect) |
View |
| 2020-12-21 Option Award |
2021-04-01 6:16 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Stampacchia Otello Director |
12,870,933 | $1.3985 | 15,120,056 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:16 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Stampacchia Otello Director |
14,670,056 | $0 | 15,120,056 (Indirect) |
View |
| 2021-03-30 Option Award |
2021-04-01 6:16 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Stampacchia Otello Director |
450,000 | $16 | 15,120,056 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:16 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
38,734,459 | $0 | 749,634 (Indirect) |
View |
| 2020-12-21 Option Award |
2021-04-01 6:14 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
10,368,251 | $1.3985 | 10,499,175 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:14 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Bonita David P Director |
13,999,692 | $0 | 10,499,175 (Indirect) |
View |
| 2020-12-21 Option Award |
2021-04-01 6:13 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
10,368,251 | $1.3985 | 10,499,175 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:13 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
13,999,692 | $0 | 10,499,175 (Indirect) |
View |
Ownership(A) |
2021-03-30 5:22 pm |
N/A 2030-07-22 |
Ikena Oncology Inc. | IKNA | Santillana Sergio L. Chief Medical Officer |
0 | $0 | 157,711 (Direct) |
View |
Ownership |
2021-03-25 8:15 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Stampacchia Otello Director |
0 | $0 | 1,799,123 (Indirect) |
View |
Ownership |
2021-03-25 8:14 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
0 | $0 | 281,466 (Direct) |
View |
Ownership |
2021-03-25 8:13 pm |
N/A 2030-07-22 |
Ikena Oncology Inc. | IKNA | Santillana Sergio L. Chief Medical Officer |
0 | $0 | 1,347,131 (Direct) |
View |
Ownership |
2021-03-25 8:12 pm |
N/A 2028-01-23 |
Ikena Oncology Inc. | IKNA | Ecsedy Jeffrey Chief Scientific Officer |
0 | $0 | 372,424 (Direct) |
View |
Ownership |
2021-03-25 8:11 pm |
N/A 2028-05-09 |
Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director |
0 | $0 | 223,840 (Direct) |
View |
Ownership |
2021-03-25 8:11 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
0 | $0 | 7,099,797 (Indirect) |
View |
Ownership |
2021-03-25 8:09 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | FORMELA JEAN FRANCOIS Director |
0 | $0 | 4,919,456 (Indirect) |
View |